Perrigo obtained federal approval for its fluticasone propionate lotion in the 0.05% strength to address inflammatory and pruritic manifestations of atopic dermatitis in pediatric patients ages 1 and older. The drug is a generic copy of PharmaDerm's Cutivate.
Perrigo's generic dermatitis drug gains FDA nod
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||